{
    "id": "dec292bf-788d-95ae-e305-7b2ca242ffc3",
    "indications": {
        "text": "lacosamide oral solution indicated : treatment partial-onset seizures patients 4 years age older ( 1.1 ) adjunctive therapy treatment primary generalized tonic-clonic seizures patients 4 years age older ( 1.2 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "adults ( 17 years older ) : initial monotherapy treatment partial-onset seizures 100 mg twice daily ( 2.1 ) initial adjunctive therapy treatment partial-onset seizures primary generalized tonic-clonic seizures 50 mg twice daily ( 2.1 ) maximum recommended monotherapy adjunctive therapy 200 mg twice daily ( 2.1 ) pediatric patients 4 years less 17 years : recommended based body weight administered orally twice daily ( 2.1 ) increase based response tolerability , frequently per week ( 2.1 ) dose adjustment recommended severe renal impairment ( 2.4 , 12.3 ) dose adjustment recommended mild moderate hepatic impairment ; patients severe hepatic impairment recommended ( 2.5 , 12.3 )",
        "doid_entities": [],
        "orphanet_entities": [
            {
                "disease": "severe hepatic impairment",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_447788"
            },
            {
                "disease": "severe renal impairment",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_447788"
            }
        ]
    },
    "adverseReactions": "none .",
    "ingredients": [
        {
            "name": "LACOSAMIDE",
            "code": "563KS2PQY5",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_135939"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        },
        {
            "name": "SORBITOL",
            "code": "506T60A25R",
            "drugbank_id": "https://go.drugbank.com/drugs/DB01638"
        },
        {
            "name": "GLYCERIN",
            "code": "PDC6A3C0OX",
            "drugbank_id": "https://go.drugbank.com/drugs/DB09462"
        },
        {
            "name": "POLYETHYLENE GLYCOL 4000",
            "code": "4R4HFI6D95",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED",
            "code": "K679OBS311",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_85146"
        },
        {
            "name": "ACESULFAME POTASSIUM",
            "code": "23OV73Q5G9",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_83501"
        },
        {
            "name": "METHYLPARABEN",
            "code": "A2I8C7HI9T",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_31835"
        },
        {
            "name": "ANHYDROUS CITRIC ACID",
            "code": "XF417D3PSL",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30769"
        },
        {
            "name": "SODIUM CHLORIDE",
            "code": "451W47IQ8X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_26710"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "ALCOHOL",
            "code": "3K9958V90M",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        }
    ],
    "organization": "Apotex Corp.",
    "name": "Lacosamide Oral Solution",
    "effectiveTime": "20250519",
    "indications_original": "Lacosamide oral solution is indicated for: Treatment of partial-onset seizures in patients 4 years of age and older (1.1) Adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients 4 years of age and older ( 1.2 )",
    "contraindications_original": "Adults (17 years and older): Initial dosage for monotherapy for the treatment of partial-onset seizures is 100 mg twice daily ( 2.1 ) Initial dosage for adjunctive therapy for the treatment of partial-onset seizures or primary generalized tonic-clonic seizures is 50 mg twice daily ( 2.1 ) Maximum recommended dosage for monotherapy and adjunctive therapy is 200 mg twice daily ( 2.1 ) Pediatric Patients 4 years to less than 17 years: The recommended dosage is based on body weight and is administered orally twice daily ( 2.1 ) Increase dosage based on clinical response and tolerability, no more frequently than once per week ( 2.1 ) Dose adjustment is recommended for severe renal impairment ( 2.4 , 12.3 ) Dose adjustment is recommended for mild or moderate hepatic impairment; use in patients with severe hepatic impairment is not recommended ( 2.5 , 12.3 )",
    "adverseReactions_original": "None.",
    "drug": [
        {
            "name": "Lacosamide Oral Solution",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_135939"
        }
    ]
}